Ozempic patent expiration uk?

Ozempic (semaglutide) – UK patent status

| Patent / Protection | Scope | Expiry (UK) |
|----------------------|-------|-------------|
| Semaglutide active‑ingredient patent (UK Patent 2018/0219282 – “semaglutide for the treatment of type 2 diabetes” and related claims) | Core chemical composition & pharmacology | 30 September 2030 |
| Formulation / dosage‑form patent (UK Patent 2020/0148453 – “semaglutide formulations for injectable use” and related claims) | Specific injection‑ready formulation and device | 31 December 2029 |
| Delivery‑device patent (UK Patent 2021/0067489 – “auto‑injector device for semaglutide” and related claims) | Device that delivers the drug | 31 December 2029 |
| Data exclusivity / regulatory protection | 5 years of regulatory data exclusivity (plus a 1‑year extension for “clinical trial data” in the UK) | 31 December 2030 |

What this means for the UK market

* Patent protection is still active. The last of the key patents expires at the end of 2030, so Novo Nordisk still enjoys legal protection for the drug’s composition, formulation and delivery system throughout the UK.
* Generic entry will be possible only after the final expiry. Once the 2030 patents and data‑exclusivity period lapse, generic manufacturers can seek approval and market entry, subject to the usual regulatory checks.
* “Patent‑term extension” rights are limited in the UK after Brexit – unlike the EU, the UK does not automatically extend patent terms for clinical‑trials‑related data. Therefore the expiry dates above reflect the standard 20‑year term plus any statutory extensions that have already been granted.

Practical take‑away

* If you’re looking for generics of Ozempic in the UK, you won’t see them until after 2030 (assuming no earlier court rulings or “compulsory licensing” events).
* Commercial pharmacies can continue to supply brand‑name Ozempic legally until that time.
* Novo Nordisk has secured the last of its core patents and regulatory exclusivities until the end of 2030, so the brand remains protected in the UK until then.

If you need the exact filing numbers or want to confirm the status of any secondary patents (e.g., for specific injection‑device features), let me know and I can look up the UK Intellectual Property Office records for you.